Venus forays into Singapore's topical pain management market

With marketing approval and patent for Trois

Venus Remedies announced that the Company has entered into Singapore's topical pain management market with a marketing authorisation and patent for its herbal nanotechnology based pain reliever Trois. The Company is holding talks with various pharmaceutical firms for tie-ups to market Trois in Singapore.

Powered by Capital Market - Live News